This same gene has been demonstrated to be correlated with CBX8 levels both in colon cancer and in NAT, emphasizing the intricate interconnection between CBX8 levels, stemness, tumor progression and resistance to therapy. The gene discussed is BRD2; the disease is colonic neoplasm.